As global health threats continue to evolve rapidly, pharmaceutical leaders face mounting pressure to design development programs that can withstand volatility. From pandemics to geopolitical unrest ...

Cantargia is eligible to receive up to USD 580 million in development, regulatory and commercial milestone payments plus earn-out payments from global product sales. Otsuka Pharmaceutical obtains ...

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX), currently trading at $9.16 and showing a remarkable 330% return over the past year, announced Wednesday that it is discontinuing the ORION program ...

A highly practical degree blending pharmaceutical and cosmetic science, equipping you with in-demand skills to design, develop, and manufacture innovative health and beauty products. On this page A ...

You deserve a positive teaching and learning experience, where you feel part of a supportive community. That’s why most of our postgraduate taught students will enjoy an innovative approach to ...

Ashland announced on Oct. 31, 2022 that FDA’s Center for Drug Evaluation and Research’s Office of New Drugs has accepted Ashland Viatel bioresorbable mPEG-PDLLA pharmaceutical excipient in the review ...

BEIJING, Oct 31 (Reuters) - China has blocked GSK plc from participating in its national bulk-buy pharmaceutical program from Oct. 31, 2022 to April 29, 2024 due to what it said were recent drug ...

Strategically Expands Jazz's Mid-Stage Neuroscience Pipeline into a New Disease Area and Further Optimizes SpringWorks' Strategic Focus on Targeted Oncology Jazz to Make Upfront Payment of $35 Million ...

NEW YORK, December 08, 2025--(BUSINESS WIRE)--Hercules Pharmaceuticals (Hercules), a national leader in pharmaceutical distribution, today announced that it has been approved as an authorized ...